Resistomap has a unique knowledge on the combination of microbial antibiotic resistance, molecular genetics and data science.
Resistomap has raised €2.0M across 1 funding round from 1 investor, most recently a Seed round in Nov 2023. Based in Helsinki, Finland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-11-15 | Seed | €2.0M |
| Ananda Impact Ventures |
| View deal → |
